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Photoactivation of rhodopsin (Rho), a G protein-
coupled receptor, causes conformational changes
that provide a specific binding site for the rod G pro-
tein, Gt. In this work we employed structural mass
spectrometry techniques to elucidate the structural
changes accompanying transition of ground state
Rho to photoactivated Rho (Rho*) and in the pen-
tameric complex between dimeric Rho* and hetero-
trimeric Gt. Observed differences in hydroxyl radical
labeling and deuterium uptake between Rho* and the
(Rho*)2-Gt complex suggest that photoactivation
causes structural relaxation of Rho following its initial
tightening upon Gt coupling. In contrast, nucleotide-
free Gt in the complex is significantly more acces-
sible to deuterium uptake allowing it to accept GTP
and mediating complex dissociation. Thus, we pro-
vide direct evidence that in the critical step of signal
amplification, Rho* and Gt exhibit dissimilar confor-
mational changes when they are coupled in the
(Rho*)2-Gt complex.
INTRODUCTION
Rho (Mr 42 kDa, 348 amino acids), a prototypical G protein-
coupled receptor (GPCR), is activated by light (Palczewski,
2006). This photoactivation involves isomerization of Rho’s
covalently bound ligand, 11-cis-retinal, to the all-trans conforma-
tion and promotes structural changes leading to the binding of
the G protein, transducin (Gt, Mr 85.6 kDa, 764 amino acids)
required for signal amplification (Jastrzebska et al., 2010,
2011a). Elucidation of X-ray crystal structures of Rho and several
Rho photointermediates have greatly increased our under-
standing of the structural rearrangements produced by photoac-
tivation (Choe et al., 2011; Deupi et al., 2012; Higgins et al., 2006;
Lodowski et al., 2007; Nakamichi and Okada, 2006a,
2006b,2007; Okada, 2004; Okada et al., 2004; Palczewski
et al., 2000; Salom et al., 2006a, 2006b; Scheerer et al., 2008;
Standfuss et al., 2007, 2011; Stenkamp, 2008; Teller et al.,826 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights2001). However, the Meta II state of Rho (Rho*) is transient,
and crystals of Rho* provide only low-resolution data because
of crystal packing alterations (Salom et al., 2006a, 2006b). The
crystal structure of opsinwith boundGt peptide at lowpH, postu-
lated to represent an active conformation of Rho*, does show
light-induced structural reorganization, such as an elongation
of the protein (Scheerer et al., 2008), but opsin does not contain
chromophore and its activity is much lower than that of Rho*
(Choe et al., 2011; Scheerer et al., 2008). Crystals of opsin
soaked with all-trans-retinal at low pH exhibit some properties
of Rho*, but this procedure did not cause transition to ground
state Rho when 11-cis-retinal was used (Choe et al., 2011), sug-
gesting that crystal packing of opsin interferes with necessary
conformational rearrangements to the native-like state (Figure 1).
Therefore, the property of Rho* that enables binding to Gt, and
more importantly the structure of Rho* in complex with Gt that
mediates signal transduction, has yet to be determined.
Membrane proteins, including Rho, employ internal water
molecules to provide a flexible link between allosteric sites
(Meyer, 1992). Yet, there are few available methods that can
monitor dynamic changes in reorganization of water mole-
cules—most notable is radiolytic footprinting, with hydroxyl
radical labeling and mass spectrometry readout, which is
emerging as a novel approach for assessing dynamics of water
(Adare et al., 2011; Angel et al., 2009a, 2009b; Orban et al.,
2010b). As shown previously, Rho and other receptors in the
GPCR family contain conserved internal water molecules
involved in mediation of the activation signal across membranes
(Angel et al., 2009a, 2009b). Long molecular dynamics simula-
tions (1.5 ms) and 1H magnetic angle spin nuclear magnetic
resonance (NMR) both indicated that increased hydration
accompanies development of Rho* and that subtle changes in
internal hydration may be important during activation (Hurst
et al., 2010). This water plays a structural role in receptor activa-
tion similar to well-recognized prosthetic groups in other pro-
teins. In hydroxyl radical footprinting experiments, significant
changes in the rates of water mediated residue modifications
in Rho upon photoactivation and transition to Rho* were
observed close to the chromophore binding pocket and toward
the cytoplasmic face of the receptor that is important for Gt
binding (Angel et al., 2009b). However, it is currently unknown
if further reorganization of internal water molecules occurs as
the Rho*-Gt complex develops, which would indicate bothreserved
Figure 1. Snapshot of Rho Activation Inter-
mediates Determined by X-ray Crystallog-
raphy
X-ray crystal structures were determined for three
distinct conformations of Rho trapped in crystals
prepared under different conditions. These are
named Rho1 (PDB entry 1u19 [Okada et al., 2004]),
Rho2 (PDB entries 3c9l [Stenkamp, 2008] and
1gzm [Li et al., 2004]), and Rho3 (PDB entries 2i35
[Salom et al., 2006b] and 2i36 [Salom et al.,
2006a]). Rho is photoactivated to form Meta II
(Rho*) capable of G protein activation. Light-acti-
vated Rho3 crystals transform to Rho* (PDB entries
2i35 [Salom et al., 2006b] and 2i36 [Salom et al.,
2006a]). Opsin, the chromophore-free form of Rho, adopts an active Gt binding state at low pH, termed opsin* (Scheerer et al., 2008). Soaking opsin* crystals
(PDB entry 3dqb [Scheerer et al., 2008]) with all-trans-retinal at low pH resulted in reversible formation of the Rho*-like state with (PDB entry 3pqr [Choe et al.,
2011]) and without the Gta C-terminal peptide (PDB entry 3pxo [Choe et al., 2011]). In the presence of Gt (transducin) Rho* forms a Rho*-Gt complex, but details
about this structure are as yet unknown. Gathering structural information about the Rho*-Gt complex was approached indirectly from two different perspec-
tives—the first started with the Rho state and the second started with the opsin* state. The only experimentally available structural model for the Rho*-Gt complex
is a recently described low-resolution electron microscopic model (Jastrzebska et al., 2011c).
Structure
Dynamics of Rhodopsin-Transducin Complexa structural and functional differences in conformation between
Rho* and Rho* complexed to Gt.
GPCRs form oligomeric structures in membranes (Park et al.,
2008). Consistent with these findings and using nucleotide
depletion, we have extracted the Rho*-Gt complex from native
biological membranes (Jastrzebska et al., 2009) or reconstituted
the complex from purified native proteins and affinity chroma-
tography (Jastrzebska et al., 2011c). The resulting nucleotide-
free Rho*-Gt complex was composed of (Rho*)2-Gt, because
its mass determined by scanning transmission electron micros-
copy was 221 ± 2 kDa and the molecular envelope calculated at
21.6 A˚ from projections of negatively stained protein particles
demonstrated a complex structure composed of two Rho mole-
cules together with one Gt heterotrimer (Jastrzebska et al.,
2011c). This provides a substrate upon which to assess struc-
tural and dynamics questions of G protein signaling in the
context of a native-like assembly of the relevant macromolecular
complexes.
The recent crystal structure of the b2-adrenergic receptor
(b2-AR) in complex with Gs has provided the highest resolution
snapshot of the interaction between a monomeric GPCR and
its cognate G protein (Rasmussen et al., 2011). Formation of
this complex involved substantial structural changes in both
proteins, including, among others, outward movements of trans-
membrane helices TM-V and TM-VI of b2-AR and a remarkably
large displacement of the helical domain as well as rearrange-
ments in the a subunit of Gs. This landmark achievement offers
invaluable insight into the mechanism of signal transduction by
a GPCR across the cell membrane. However, the addition of
a T4 lysozyme molecule to the amino terminus of b2-AR and the
presence of a single-domain antibody necessary for stabilization
of thecomplexmayblock other important dynamics necessary to
the native activation mechanism. To take full advantage of this
valuable static view of aGPCRbound to its G protein, application
of experimental techniques capable of capturing the behavior
and dynamics of the complex in solution is critical. Thus, recent
studies using hydrogen-deuterium exchange experiments that
characterized the dynamics of the b2-AR alone (Zhang et al.,
2010) and in the presence of ligands (West et al., 2011) are quite
valuable. The dynamics of Gs protein induced by b2-AR was alsoStructure 20studied (Chung et al., 2011), where presumably 1:1 complex
between the receptor and G protein was formed.
In the current study, we employed structural MS, including
radiolytic footprinting and hydrogen-deuterium exchange, to
investigate dynamic differences in the Rho structure that occur
upon photoactivation and binding to Gt. Both methods are very
well suited for the measure of solvent accessibility. However,
there are some notable differences that make their use not
redundant but rather complementary. First, the timescale for
radiolytic footprinting is on the order of ms, whereas the time-
scale for the hydrogen-deuterium exchange is on the s or min
timescale. Second, radiolytic footprinting was recently shown
to be a unique tool to study internal water dynamics. Our study
also investigated the dynamics of a GPCR, including its internal
water molecules, induced by its G protein binding together with
an examination of the dynamics of Gta induced by dimeric Rho*.
This assessment of the pentameric complex is compared to
existing structural and dynamic data to extend models of G
protein activation and dynamics.
RESULTS
Functional Characterization of Rho, Rho*,
and Rho*-Gt Preparations
To visualize dynamic changes in Rho upon activation and
binding its heterotrimeric G protein (Gt) by proteomics methods
we used well-characterized preparations composed of high-
purity-protein components with defined stoichiometry that
retained appropriate enzymatic activities (see Experimental
Procedures). Rhowas purified by ZnCl2-opsin extraction and de-
lipidated by succinylated Concanavalin A (sConA) affinity chro-
matography. The native-like (Rho*)2-Gt complex was isolated
by sConA affinity chromatography as recently described (Jastr-
zebska et al., 2011c). The complex was formed only after Rho
was photoactivated, and it could be eluted from the column
with a-methyl-D-mannoside. (Rho*)2-Gt dissociated to individual
subunits when 200 mM GTPgS was added, indicating that the
complex retained its native-like biochemical activity. The purified
complex exhibited an absorbance maximum at 380 nm and
retinoid analysis showed that the major chromophore isomer, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 827
Figure 2. Radiolytic Footprinting of Rho, Rho*, and Rho*-Gt Complex
(A) Shows a two-dimensional map of Rho, where amino acid residues, modified following exposure to high-flux X-rays, are shown as red filled circles. The
complete list of residues unambiguously identified as being modified following X-ray exposure includes W35, M44, M49, P71, M86, A117, A124, M143, M155, M163,
M183, P194, M253, P285, M288, P303, M317, and A346.
(B) Shows the X-ray crystal structure of Rho (PDB entry 1u19 [Okada et al., 2004]) represented as gray cartoons. Amino acid residuesM86, M163, M288, P303, M253,
and A346 are represented by spheres. The color coding represents the percent of differences between rates of Rho* and Rho*-Gt labeling normalized to Rho*-Gt
rates.
(C) Tabulates modified amino acid residues (shown in red letters) with their modification rates in Rho, Rho*, and the Rho*-Gt complex.
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was free of nucleotides based on high-performance liquid chro-
matography (HPLC) nucleotide analysis. After X-ray irradiation
for footprinting analysis, spectral properties of Rho and the
Rho*-Gt complex did not exhibit major changes and gel analysis
did not show a significant amount of amide bond cleavage as
previously reported (Angel et al., 2009b). Individual proteins
and the complex were subjected to radiolytic footprinting (Adare
et al., 2011; Angel et al., 2009a, 2009b; Orban et al., 2010b) and
hydrogen-deuterium exchange (Busenlehner and Armstrong,
2005); next, proteins were cleaved proteolytically, and the gener-
ated peptidic fragments were identified and quantified by MS.
Control experiments involved the use of synthetic peptides.
Optimization of Proteolysis of Rho and Gta with Pepsin
and Peptide Separation Yielded High Coverage
for Both Proteins
Successful rapid digestion and peptide separation of proteins
with multiple TM domains is still challenging, and optimization of
digestion conditions is essential (Konermann et al., 2011). We
found that the 10 min digestion of Rho and Gta with pepsin for
the hydrogen-deuteriumexchange experiments resulted in an ex-
cellent sequence coverage ranging from 83%–90% for Rho and
82%–87%for thealphasubunit ofGt. Forovernightpepsindigests828 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rightsof Rho employed for radiolytic footprinting studies, the sequence
coverage was even higher (typically >95%). Because we em-
ployed highly purified proteins, the spectra were devoid of extra-
neous peptides. The quality of identification was based on three
independent scoringmodels—twostatistical andonedescriptive.
Based on parameters described in detail elsewhere, all peptides
we considered identified had pp or pp2 scores higher than six,
indicating statistical significance (Xu and Freitas, 2009a).
Binding of Gt to Rho* Changed Internal Water Reactivity
as Determined by Radiolytic Footprinting
To identify changes in internal waters reorganization that
resulted from Rho photoactivation and the complex formation
with Gt, we used X-ray-induced radiolytic footprinting. In this
hydroxyl radical labeling approach, we identified eighteen
peptide fragments that were modified after exposure to high-
flux X-rays (Figure 2A). These peptides encompassed fragments
of the sequence derived from TM-VI (W35, M44, M49, P71, M86,
A117, A124, M143, M155, M163, M253, P285, M288, P303, and M317),
the plug region of the chromophore (M183 and P194), and the
C-terminal region (A346). These modifications were consistently
identified in all preparations. Scoring functions used for identifi-
cation were identical for bothmodified and unmodified peptides.
Dose response plots were constructed for five peptidereserved
Figure 3. Radiolytic Footprinting of Rho, Rho*, and Rho*-Gt
Dose plots showing fraction unmodified (see the Experimental Procedures subsection ‘‘Radiolytic Footprinting’’) as a function of exposure time (ms) were
constructed for six peptides from a total of 18 that showed modification after exposure to X–rays (see Figure 2A, in red). These were analyzed as described in the
Experimental Procedures subsection ‘‘Radiolytic Footprinting’’.
(A) Shows fragment ASTTVSKTETSQVA346PA, (B) shows fragment FM86VFGGF, (C) shows fragment TWV163MA, (D) shows fragment FAKTSAVYNP303VIY, (E)
shows fragment M288TIPAF, and (F) shows fragment SATTQKAEKEVTRM253. In all panels peptide fragments obtained from Rho samples are indicated by black
squares, Rho* by red spheres, and Rho*-Gt by blue triangles. Error bars represent SEM, and statistical significance was assessed by the Student’s t test. Data
represent at least three independent experiments.
Structure
Dynamics of Rhodopsin-Transducin Complexfragments that provided reproducible and reliable quantification
for all three states of Rho examined (Figures 3A–3E) and one for
a peptide fragment identified only in the case of the Rho*-Gt
complex (Figure 3F). The modification rate of the C-terminal
peptide fragment denoted as ASTTVSKTETSAVA346PA was
the highest in the Rho*-Gt complex. Fragments identified as
FM86VFGGF, FAKTSAVYNP303VIY, and M288TIPAF showed
significant differences in oxidation rate between Rho*-GtStructure 20complex as compared with Rho and Rho* (Figures 3B, 3D,
and 3E) although the error of the measurements was higher
for these peptides as compared to the peptide fragment
ASTTVSKTETSAVA346PA. Modification rates for the TWVM163A
fragment, although high, showed no difference between the
three states of Rho (Figure 3C). The changes in rates can be
attributed to reorganization of locally trapped waters within the
core of the protein (Angel et al., 2009b; Orban et al., 2010b)., 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 829
Figure 4. Typical Flowchart of the Hydrogen-Deuterium Exchange Analysis
(A) Shows a typical chromatogram depicting relative intensities (%) of the signal as a function of elution time (min) obtained after the digestion of Rho with pepsin
(details are described in the Experimental Procedures subsection ‘‘Amide Hydrogen-Deuterium Exchange of Rho’’).
(B) Shows m/z = 736.9 spectrum at the 11.3 min retention time, based on the HPLC chromatogram presented in (A).
(C) Shows the MS/MS of m/z = 736.9 doubly charged ion together with the y and b ions assignments used to identify the Rho peptic peptide fragment
F294AKTSAVYNPVIY.
(D) Provides a detailed view of the isotopic distribution of the undeuterated (0% D2O) m/z = 736.9 ion previously shown in (B) and identified in (C).
(E) Shows a detailed view of the isotopic distribution of fully deuterated (100% D2O) pepsin-digested Rho fragment F
294AKTSAVYNPVIY.
(F) Hydrogen exchange plot of peptide fragment (F294AKTSAVYNPVIY) as a function of incubation time (s). The Rho hydrogen-deuterium exchange procedure
and digestion parameters are described in the Experimental Procedures subsection ‘‘Amide Hydrogen-Deuterium Exchange of Rho.’’ Deuterium uptake is shown
as a percentage calculated as described in the Experimental Procedures subsection ‘‘Analysis of Deuterium Exchange’’ (see also Table S1 and Figure 4). The
percent uptake at different time intervals (0 to 1,800 s) for Rho is shown by filled black squares, for Rho* by filled red circles, and for the Rho*-Gt complex by filled
blue triangles. Error bars represent SEM, and statistical significancewas assessed by the Student’s t test. Data represent at least three independent experiments.
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Dynamics of Rhodopsin-Transducin ComplexInsight into Rho* and Gt Dynamics from Hydrogen-
Deuterium Exchange
Hydrogen-deuterium exchange coupled to MS is a powerful
method to study protein dynamics (Busenlehner and Armstrong,830 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights2005; Konermann et al., 2011). Each hydrogen-deuterium exper-
iment was carried out following the same workflow (Figure 4). A
primary concern after quenching the exchange reaction is to
minimize back exchange of deuterium to hydrogen during thereserved
Figure 5. Hydrogen-Deuterium Exchange Control Experiments with
Synthetic Peptides
(A) Shows deuterium uptake by the synthetic peptide with the sequence
MTIPAF. Deuterium uptake by the peptic peptide fragment M288TIPAF from
Rho samples is shown in white, uptake by the Rho* sample is shown in light
gray, and uptake by the Rho*-Gt sample is shown in dark gray. The uptake by
the synthetic peptide in the presence of DDM is shown in black. Deuterium
uptake evaluated when the peptide was injected without exposure to the
HPLC column is shown in dense pattern, and the 80% theoretical uptake
based on the described experimental conditions is shown in sparse pattern
(see Experimental Procedures).
(B and C) show deuterium uptake by two other synthetic peptides
F294AKTSAVYNPVIY and T336VSKTETSQVAPA, respectively. Deuterium
Structure
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Structure 20HPLC separation and MS analysis. This was achieved by
lowering the sample and HPLC column temperature to 2C–
4C concomitantly with careful control of the sample pH.
Hydrogen-deuterium exchange control experiments using
synthetic peptides derived from the Rho primary sequence
(C-terminal peptide and the chromophore binding site) spiked
into explicitly measure back exchange determined that back
exchange was minimal (3%) during the pepsin digest period
but was influenced by the retention time of the peptide on the
column. This back exchange during the HPLC separation was
found to be in the 10%–30% range (Figures 5A–5C). Typical
plots (Figures 6A–6F; see also Tables S1 and S2, available on-
line) were represented as color-coded uptakes in Rho and Gta.
In essence, these back-exchange control experiments provide
benchmarks for comparisons to protein experimental data.
For Rho purified in detergent-lipid mixed micelles, deuterium
uptake was minimal. Normalized values for each state are
shown in the supplement (Figures S1A and S1B). The only region
with significant exchange was the C-terminal peptide
T336VSKTETSQVAPA (Figure S1A, in red, compared to Fig-
ure S1B, in pink). The TM regions generally resisted exchange,
with the exception of peptides in close vicinity to the chromo-
phore binding site (F294AKTSAVYNPVIY), where exchange ap-
proached 30%. Following light activation of Rho, several regions
had altered deuterium uptake profiles. Although the whole mole-
cule showed increased deuterium uptake, several peptide
fragments showed a considerable increase compared with the
dark form of Rho (Figure 7A). These fragments were located in
the cytoplasmic loops C-II and C-III (F146RFGENHAIMG and
T229VKEAAAQQQESATTQ), the chromophore-binding site
(F294AKTSAVYNPVIY), and theC-terminus (T336VSKTETSQVAPA).
Uptake in the TM regions of Rho* was in the range of 10% to 20%
as opposed to <10% in the case of Rho. Comparing Rho in de-
lipidated form with Rho with the sample containing phospho-
lipids, we found that regions that show decreased uptake
compared to Rho were located in the CI and EIII domains
(Figure 7B). Interestingly, more TM regions seem to have
decreased uptake upon activation (Figure 7B, in green).
When lipids were completely removed during the purification
procedure, the differences between Rho and Rho* were less
prominent although exchange overall was consistently higher.
For example, differences in the TM-I, TM-II, and C-I regions
were insignificant, but some peptides from TM-IV showed
increased deuterium uptake in the Rho* form (Figure S1D, green;
compare to Figure S1C, in dark cyan; compare to Figure S1C,
dark cyan). Another difference was in the C-terminal segment
of Rho, which showed 70% deuterium uptake (Figure S1C, in
orange) as compared to >80% in the same region of Rho* (Fig-
ure S1D, pink). Because this purification method for Rho was
comparable with the Rho*-Gt complex method, we were able
to compare these states. The Rho*-Gt sample overall showed
a decreased uptake in deuterium (50%, Figure 8A, normalizeduptake by peptic peptides obtained from Rho samples is shown in white, by
peptides obtained from Rho* samples in light gray, and by peptides obtained
from Rho*-Gt in dark gray. Deuterium uptake by the synthetic peptides
F294AKTSAVYNPVIY and T336VSKTETSQVAPA in the presence of DDM is
shown in black.
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Figure 6. Normalized Deuterium Uptake of Representative Rho Peptide Fragments in Rho, Rho*, and Rho*-Gt
Normalized deuterium uptake is shown as a function of exchange time (A, M285TIPAF; B, T336VSKTETSQVAPA; C, V11PFSNKTGVVRSPFEAPQYY;
D, Y60VTVQHKKLRTPLNYIL; E, Y30LAWPWQFSMLAAYMFLLIMLGFPINF; and F, Y191YTPHEETNESF). Plots were constructed from normalized deuterium
uptakes evaluated after incubating samples for designated specific periods (s) in D2O followed by a 10 min digest. In all six panels, peptide fragments obtained
from Rho samples are shown as black squares, Rho* as red spheres, and Rho*-Gt as blue triangles. Error bars represent SEM, and statistical significance was
assessed by the Student’s t test. Data represent at least three independent experiments.
See also Tables S1 and S2.
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Dynamics of Rhodopsin-Transducin Complexvalues for each state are shown in Figure S2); however, this was
reflected as both increases and decreases in exchange for
specific peptides compared to Rho and Rho*. The first extracel-
lular loop (E–I) had uptakes of <20% in the case of Rho and Rho*,
whereas the uptake in the Rho*-Gt complex was increased to
40% (Figures S1C and S1D, in blue; compare to Figure S2A,
in green). The E-II peptide W175SRYIPEGMQ had an uptake of
10% in the Rho state, an increase to 40% in Rho*, and reached
50% in the Rho*-Gt complex (Figure S1C, in cyan; Figure S1D, in832 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rightsgreen and Figure S2, in yellow). The TM-VI, E-III, and TM-VII
regions in Rho* (Figure S1D) exhibited a decreased uptake
when compared with Rho (Figure S1C). These regions become
even more resistant to deuterium exchange in the Rho*-Gt
complex (Figure 8A).
Comparison of the domain arrangement in the Rho*-Gt three-
dimensional model obtained from electron microscopy images
with the available X-ray structure of the b2-AR showed a major
disagreement in the organization of the a domain (Figures 8Breserved
Figure 7. Differences in Normalized Hydrogen-Deuterium Exchange
in Rho* and Rho in the Presence and Absence of Lipids
(A) Shows differences between Rho* and Rho purified in the presence of lipids.
(B) Shows differences between Rho purified in the presence of lipids and Rho
purified in the presence of detergent.
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Structure 20and 8C). Hence, we focused our analysis to the a domain of Gt.
When Gt was in complex with Rho*, the deuterium uptake of the
Gta subunit was found to be increased as denoted by the positive
differences between the Rho*-Gt state versus the free Gt
state (Figures 9A and 9B). Normalized values for each state are
shown in Figure S3. In contrast, deuterium uptake of free Gta
was found to be reduced when compared to Gt in the (Rho*)2-
Gt complex (Figures S3B and S3C). For the majority of the
peptic peptides resulting from the pepsin digest of Gta, maximal
uptake was obtained after only 30 s of D2O incubation as
opposed to the 10 min incubation needed in the case of the
Rho or Rho* molecule. The larges changes were observed for
the following Gta fragments: A
7EEKHSRELEKKLKEDAEKDART
(31%), L33LLGAGESGKSTIVKQ (38%), L33LLGAGESGKSTIVK
QMKIIHQDGYSLE (22%), E157RLVTPGYVPTEQD (59%), and
T321CATDTQNVKFVF (32%).
DISCUSSION
We first investigated different preparations of Rho. We found
major differences in hydrogen-deuterium uptake among
different states of Rho (Figure 7). These differences are attributed
to the presence or absence of lipids or activation of Rho. We
have also investigated the (Rho*)2-Gt complex reconstituted
from native purified proteins and subjected it to hydroxyl radical
footprinting and hydrogen-deuterium exchange. Our results
directly identified reorganization of water molecules in different
states of Rho* and identified dynamics regions in both Rho*
and Gt. The observed rates of hydrogen-deuterium exchange
were compared to control experiments, where individual
proteins were investigated. Because the complex is highly deli-
pidated, the Rho sample in either delipidated or in the mixed
micelles of detergent and lipids were also compared with each
other. Finally, we identified the conformational dynamics of
activation for the pentameric complex of dimeric Rho* and
heterotrimeric G protein.
Although Rho* in the Rho*-Gt complex exhibits the same
UV-vis spectral properties as isolated Rho* (Jastrzebska et al.,
2011c), the conformations of both states most likely are not
the same. Indeed, Fourier transform infrared (FTIR) studies of
the interaction between Rho* and Gt-derived peptide revealed
that formation of the complex between these two entities is
accompanied by structural changes in both (Vogel et al., 2007).
This indicates that the conformation of Rho* in the Rho*-Gt(C) Shows differences between Rho* and Rho purified in the presence of
detergent. A two-dimensional plot of the Rho primary sequence is used to
represent the differences of normalized uptakes identified for the peptic
fragments between states. After representation of the actual percent uptake as
a function of D2O incubation time (typical plots are shown in Figures 6A–6F),
values were corrected to account for sample dilution (see the Experimental
Procedures subsection ‘‘Hydrogen-Deuterium Exchange Analysis’’ for a
detailed description in). Differences between states were evaluated using
normalized values of the uptake obtained after 10 min incubation in D2O and
are recorded in Table S1 (columns 6 to 10). Positive differences between states
were represented using the following color-coding: 0%–9%; yellow, 10%–
19%; light orange, 20%–29%; orange, 30%–39%; red, 40%–49%; pink.
Negative differences were color coded as follows: 0%–9%; green, 10%–19%;
cyan, 20%–29%; light blue, 30%–39%; blue, 40%–49%; dark blue.
See also Figure S1.
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Figure 8. Differences in Normalized Hydrogen-
Deuterium Exchange between Rho*-Gt Complex
and Rho* Purified in the Presence of Detergent
(A) Shows the differences in normalized deuterium uptake
between Rho*-Gt and Rho purified in the presence of
detergent. Calculation of the differences in normalized
deuterium uptake and the color-coding employed were
identical with what was described for Figure 7.
(B) Shows a recent model of the Rho* interaction with Gt
constructed from electron microscopic images (Jastr-
zebska et al., 2011c). The two monomers of Rho* are
shown in red and yellow (front view and a 90 rotated view).
The palmitoyl chains are shown as pink sticks, whereas
the Gt molecule domains are shown in blue, green, and
cyan. Chains of the Gt protein are colored as follows: Gas in
blue; Gb in cyan; and Gg in green.
(C) Shows an X-ray structure of the b2AR-Gs complex
(PDB 3sn6; Rasmussen et al., 2011). The b2AR is shown in
yellow, whereas the coloring of the Gs chains is kept
similar to that shown for the Gt molecule in (B). The T4
lysozyme and the Nanobody-35 present in the X-ray
structure were deleted to facilitate easy viewing.
See also Figure S2.
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Figure 9. Differences in Hydrogen-Deuterium Exchange of Free Gta
and in Complex with Rho*
(A) Illustrates a recently described Rho*-Gt model (Jastrzebska et al., 2011c).
The Rho* dimer is shown in gray. The location of Gta in the complex is shown
together with color-coding, indicating differences in percentage uptake (see
also Table S2) between the Rho*-Gt and free Gt states as described in Figure 7.
The Gtb and Gtg domains are shown in gray.
(B) Shows a 90 rotated view of the Gta domain of Gt.
See also Figure S3.
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structures of Rho intermediates available to date provide snap-
shots of specific, static states of interest, the protein dynamics
during the activation event are also of interest in understanding
the activation mechanism. Derived from recent studies with solid
state 2H NMR, a multistage activation mechanism is proposed in
which retinal isomerization initiates fluctuation of the helices and
cytoplasmic loops in the development of Rho* (Struts et al.,
2011a, 2011b). Contrary to the previous activation model, where
Rho* was considered to exist in a single conformational state, in
this latest model it is proposed that release of the block induced
by the inhibitory retinal results in not one but rather an ensemble
of conformations. This provides a relaxation of local structural
constraints that drives transient exposure of the Gt recognition
motif on the cytoplasmic surface of Rho* leading to productive
complex formation.
Two other aspects of the activation process must be consid-
ered. First, oligomerization of GPCRs may be critical in the
activation process (Fotiadis et al., 2003, 2004; Rivero-Mu¨ller
et al., 2010). Propensity of GPCRs to oligomerization in
biosynthesis (Mansoor et al., 2006), to likely stabilization at the
plasma membranes, and in diversification the GPCR signal by
heterodimerization (Park and Palczewski, 2005), suggests the
necessity to consider oligomeric structures (at least the dimer)
of GPCR and G protein (Palczewski, 2010). It is undisputed
that a single Rho* can activate a Gt pool as demonstrated elec-
trophisologically (Baylor et al., 1979) and supported by some
biochemical evidences (Bayburt et al., 2007; Whorton et al.,
2007). However, oligomerization is particularly evident in rod
cells, where in specialized ROS membranes Rho is present atStructure 205 mM concentration (Nickell et al., 2007). Second, close inspec-
tion of the X-ray structures of Rho (Protein Data Bank [PDB]
entries: 1u19 [Okada et al., 2004]), 3c9l [Stenkamp, 2008],
1gzm [Li et al., 2004], 2i35 [Salom et al., 2006b], and 2i36 [Salom
et al., 2006a]) show that a water molecule network situated close
tomodified amino acid residues that were found to be oxidized in
the footprinting experiments (i.e., M86, M288, and P303). M86 is
located in TM-II and M288 is at the interface between EC-III and
TM-VII, whereas P303 is found in TM-VII. The role of both oligo-
merization and water networks are of great interest in the
activation process.
Hydroxyl radicals generated from the trapped water mole-
cules are likely to react with nearby amino acids at high rates
because of proximity (Angel et al., 2009b; Orban et al., 2010b).
In contrast, hydroxyl radicals originating from bulk water mole-
cules may suffer quenching upon diffusion through interaction
with lipid or react with other hydroxyl radicals (Angel et al.,
2009b; Orban et al., 2010b). This in turn will result in lowered
efficiency in protein modification. M86, M253, and M288 are
located within the TM-II, TM-VII, and TM-VI regions of Rho,
respectively. The side chains of these residues are facing
inwards and are located in the vicinity of the internal water
molecular network of Rho. The importance of this internal molec-
ular network is emphasized by theM257Ymutation, which results
in a constitutively active Rho (Deupi et al., 2012). The recent X-
ray structure of the constitutively active Rho molecule bearing
the M257Y mutation argues that the internal-water-molecule-
mediated bonding network is disrupted after the mutation and
hence prevents the chromophore-induced helix movement
(Deupi et al., 2012). Superposition of the dark-state Rho (Okada
et al., 2004) with Rho* (Choe et al., 2011) shows a different orga-
nization of the internal water molecule network. Furthermore,
amino acid residues M86, M253, and M288 are localized in regions
that show conformational changes upon Rho activation. The
activation process that involves conformational changes in
TM-V and TM-VI could explain differences in the oxidation
pattern of these residues. Although TM-II does not show confor-
mational changes to the extent seen in TM-V and TM-VI, a careful
analysis shows an increase in the root-mean-square displace-
ment between the two states, especially in the kink of the helix
located in the vicinity of M86.
Because hydrogen-deuterium exchange is favored in regions
that are solvent exposed and have unstable or unstructured
secondary structure, we expected that peptides exhibiting
both characteristics within Rho would show deuterium uptake,
whereas TM regions would be relatively protected. When Rho
in a delipidated form was compared with Rho in mixed micelles,
an increased deuterium exchanged was observed for peptides
encompassing the C-I (Y60VTVQHKKLRTPLNYIL) and E-III
(Y271IFTHQGSDFGPIF) domains. When Rho was compared
with Rho*, each purified in the presence of lipids, we observed
a considerably higher deuterium uptake by Rho* (Figure 7A).
Specifically, higher deuterium exchange was observed in the
case of Rho* in the C-terminus region, the cytoplasmic loops
CI, C-II, and C-III and extracellular loop E-III. The TM region
showed similar increase in the activated form of Rho, except
for a small region located on helix VI (in green). The N-terminus
and the extracellular domain II were found to have less exchange
in the Rho* state when compared to Rho., 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 835
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hydrated (Jastrzebska et al., 2011b) or more unstructured,
consistent with 2H NMR experiments (Grossfield et al., 2008).
This difference between the Rho and Rho* was also significant
for delipidated affinity purified proteins (Figure 7B). However in
this case, the differences cannot be simply interpreted as in
the first case. The reason is that in the delipidated samples
several regions undergo increased deuterium uptake in the
Rho*, but other regions have decreased uptake when compared
to ground state Rho. Delipidation resulted in increased uptake in
some regions and decreased uptake in others. This could be
possibly attributed to the fact that the delipidated Rho samples
would be preferentially inmonomeric form, whereas the lipidated
samples Rho would be mostly found in its oligomeric form
(Borochov-Neori et al., 1983; Jastrzebska et al., 2006). These
results also point out difficulties in interpretation of experimental
data for samples that necessitate the use of detergent, like 3D
crystallography.
Our recent electron microscopic model of the Rho*-Gt
complex (Figure 8B) differs from the X-ray structure of the
b2AR-Gs protein complex (Figure 8C) in two important ways.
First, with respect to the Rho*-Gt complex, the envelope ob-
tained from electron microscopic reconstruction closely accom-
modates one Rho dimer molecule together with one Gt protein
heterotrimer. Second, the orientation of the G protein is different
in the Rho*-Gt complex than in the b2AR-Gs complex (Figures 8B
and 8C). Although the resolution of the X-ray structure of the
b2AR-Gs protein complex is the highest to date (3.2 A˚ for
a GPCR in complex with its G protein; Rasmussen et al., 2011)
and offers a molecular view of its mechanism of action, the crys-
tallization required the presence of the b2AR N-terminally fused
T4 lysozyme andNanobody-35. The specific influence that these
additions have on the final crystallographic packing is not
known. The other working model of a GPCR with its G protein
is based on electron microscopy and has a resolution of
21.6 A˚. This was obtained without any other protein adjuvant,
thereby considerably lowering the chance of artifacts introduced
into the final structure (Jastrzebska et al., 2011c). Differences are
also observed in the opening between the two G protein
domains, which consists of a 160 rotation of the a-helical
domain from the Ras-like domain within the a subunit (Jastrzeb-
ska et al., 2011c; Rasmussen et al., 2011). However, the nucle-
otide-free complex would be short-lived to accommodate such
a large conformation opening and the rebound nucleotide
(GTP) will cause rapid complex dissociation to individual
proteins. For example, Majumdar et al. (2004) found that the
exchange of GDP-GTP for the Rho*-Gt complex was 13.2 s
1
under physiological conditions.
Thus, the C-terminal region in Rho with the sequence
T336VSKTETSQVAPA (Figure 2A) is an unstructured sequence
expected to be solvent exposed (Cai et al., 1997; Langen
et al., 1999; Palczewski et al., 1991); indeed, this peptide
fragment exchanged 80% of its theoretically maximum
exchangeable sites in both Rho and Rho* (Figures S1A–S1D).
However, deuterium uptake by the same peptide sequence
was reduced in the Rho*-Gt complex, revealing decreases in
solvent accessibility or increases in the ordering of this region
or both (Figure 8A). Other studies have suggested that the region
close to the T336VSKTETSQVAPA peptide is involved in the836 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rightsinteraction with the Gt protein (Phillips and Cerione, 1994). This
positioning of peptide T336VSKTETSQVAPA in the Gt interaction
site may account for the decreased exchange pattern in the
Rho*-Gt complex.
As for the TM domains, most peptide fragment sequences we
examined did not exchange deuterium as expected, for
example, peptide M288TIPAF, but there also were exceptions,
such as F294AKTSAVYNPVIY. This apparently counterintuitive
exchange could be explained by a selective increase in intra-
membranous hydration when Rho is activated to Rho* or in the
context of conformational rearrangements as part of Gt complex
formation (Jastrzebska et al., 2011b; Grossfield et al., 2008).
Our footprinting experiments revealed that several regions
of Rho* in the Rho*-Gt complex, such as the C-terminus
(A333STTVSKTETSQVAPA), the chromophore binding site
(F294AKTSAVYNPVIY and M288TIPAF), and transmembrane
regions (FM86VFGGF), had considerably higher modification
rates when compared with their counterparts in Rho or Rho*.
As increased modification is correlated with side-chain associa-
tion with stable water molecules, this could constitute strong
evidence for a considerably extendedmolecular network ofwater
in the transmembrane region of the Rho*-Gt complex near these
modified side chains compared to the case for Rho or Rho*.
In lipid-free purified Rho, the regions from C-III to TM-VII
becomemore resistant to deuterium exchange in the Rho* state.
This reduced uptake could be attributed to formation of a
secondary structural element as indicated in the X-ray structure
of the Rho* state (Choe et al., 2011). A recent study from our
laboratory with 18O-labeled water found that water from bulk
solvent, but not tightly bound internal water, is involved in the
release of chromophore from its Rho binding site following acti-
vation (Jastrzebska et al., 2011b). Access of bulk water to the
TM region of Rho could explain the observed deuterium uptake
in these transmembrane regions. Deuterium uptake is also
reducedwhenapeptide sequenceadopts a secondary structure,
such as is the case for a TM domain that exists as an a-helix. In
this context, our results provide evidence that the region encom-
passing amino acidsF294 toY306 behave similarly to a longitudinal
stretch along the axis of the a helix in the seventh TM.
In conclusion, complementary radiolytic footprinting and
deuterium exchange studies of purified bovine Rho, Rho*, and
Rho*-Gt complexes suggest that Gt protein binding imposes
a different structural state of Rho as compared to its activated
or ground states. We have also demonstrated that changes in
detergent versus mixed micelles of detergent and phospholipids
influence the conformation of Rho, suggesting the importance of
investigating the complex in a native membrane environment.
The apparent differences in hydroxyl radical labeling and deute-
rium uptake between Rho* and the Rho*-Gt complex suggest
that light exposure causes structural relaxation of Rho followed
by tightening upon Gt coupling. Allosteric communication
between the chromophore binding site in Rho* and nucleotide-
binding site of the G protein at a distance of 50–60 A˚ is
achieved by subtle conformational changes that include also
reorganization of internal water molecules as demonstrated in
this study. Our results also suggest that binding of Gt confers
more stabilizing effect on Rho* that resembles Rho in its rigidity.
This observation stands in sharp contrast to the highly dynamic
structure of Rho* that forms a constellation of conformers.reserved
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Purification of Rho, Gt, and Rho*-Gt Complex
Bovine ROS membranes were prepared from fresh retinas under dim red
light by step sucrose gradients as described in Papermaster (1982). Rho
was purified from ROS membranes solubilized in DDM by a ZnCl2-opsin
extraction procedure (Okada et al., 2000). ZnCl2 was then removed by dialysis
in the presence of 0.2 mM DDM. Gt was purified from dark-adapted
bovine ROS membranes by extraction with hypotonic buffer as described
elsewhere (Goc et al., 2008). The Rho*-Gt complex was purified by succiny-
lated Concanavalin A affinity chromatography as described in Jastrzebska
et al. (2011c).
Radiolytic Footprinting
A similar workflow sequence for footprinting experiments was used for Rho,
Rho*, and the Rho*-Gt complex purified by sConA resin. Experiments were
initiated by exposure of each sample to high-flux synchrotron X-ray radiation
at the beamline X28C of National Synchrotron Light Source as in our previous
studies (Angel et al., 2009b; Orban et al., 2010b). Exposure times were set to 0,
1, 2.5, and 5 ms and were controlled by a Kintek apparatus described else-
where in detail (Gupta et al., 2007, 2010). Samples then were quenched by
addition of methionine amide (10 mM, final concentration) and each 100 ml
aliquot was flash frozen with dry ice and stored at 80C. Samples (100 ml)
were chemically reduced by the addition of DTT (5 mM, final concentration)
for 45 min at 37C and alkylated for 1 hr in the dark with iodoacetamide
(10 mM, final concentration) dissolved in 25 mM NH4HCO3. Proteins were
precipitated by addition of 400 m acetone and kept at80C overnight. Protein
pellets were resuspended in 5 ml of formic acid, and the volume was raised to
100 ml with water. Next, samples were digested with pepsin overnight at 23C.
Samples were desalted with a C18 UltraMicro Tip column (The Nest Group
Inc., Southborough, MA, USA). Liquid chromatography-tandem MS (LC-MS/
MS) was performed with a LTQ-Orbitrap XL linear ion trap MS (Thermo
Finnigan, Bremen, Germany) equipped with a nanospray source operated in
a positive ion mode. HPLC separation was accomplished with an UltiMate
3000 parallel LC system (Dionex Inc., Sunnyvale, CA, USA). The protein digest
(5 ml) was injected onto a reversed-phase C18 PepMap trapping column
(0.3 mm3 5mm, 5 mmparticle size; Dionex Inc.) and washed with 0.1% formic
acid. Peptides then were eluted off the trap column onto a reverse-phase C18
Acclaim PepMap 100 column of 0.075 3 150 mm (Dionex Inc.) by using
a gradient of acetonitrile running from 5% to 60% in 0.1% formic acid over a
period of 60 min at a flow rate of 300 nl/min. Spectra were acquired in
a data-dependent manner consisting of a full scan followed by a MS/MS
scan of the five most abundant precursor ions at the normalized collision
energy of 30%. Dynamic exclusion was applied to exclude multiple MS/MS
analyses for the same peptide. Identification of peptides was achieved with
the online version of MassMatrix, and the data were searched with the Rho
primary sequence used as the database. Parameters chosen for peptide iden-
tification were error tolerance for precursor ion m/z values set at 10 ppm, error
tolerance for the fragmented product ion m/z values set at 0.8 Da, mass type
set to monoisotopic, and maximum peptide length set at 40 amino acids. The
quality of the peptide search for modified and unmodified peptides was
evaluated by three statistical scores: pp, pp2, and pptag set at 5, 5, and 1.3,
respectively, as described in detail elsewhere (Xu and Chance, 2007). Peptide
fragments of Rho were identified by MS/MS analysis. The score for each
peptide was evaluated and checked for statistical significance. All reported
peptides were identified with a p value < 0.005. Side-chain modifications
were introduced within the MassMatrix search criteria based on values previ-
ously reported (Xu and Chance, 2004, 2005; Xu et al., 2003). Following identi-
fication of unmodified and modified peptic peptide fragments, the fraction
unmodified was calculated for each exposure time by using the following
formula:
Fraction unmodified=
Au
ðAu +AmÞ;
where Au represents the area under the total ion current of the unmodified
peptic peptide fragment, and Am represents the area under the total ion current
of the modified peptic peptide fragment. The area under the total ion current
was evaluated based on a semiautomatic procedure implemented in Prot-Structure 20MapMS (Kaur et al., 2009), and this wasmanually verified by using the XCalibur
2.1.0. Qual Browser.
Amide Hydrogen-Deuterium Exchange of Rho
These experiments were done in the dark under dim red light. Amide
hydrogen-deuterium exchange was performed as follows. About 25 mg of
ZnCl2-opsin-extracted Rho, affinity-purified Rho, Rho samples exposed to
light for 30 s through a 480–520 nm band pass filter (150 Watt filer light; Dolan
Jenner Industries Inc., Boxborough, MA, USA) or purified Rho*-Gt complex
were diluted in 80 ml D2O containing 0.2 mM DDM and kept on ice for 10,
30, 60, 300, 600, or 1,800 s. After exposure to deuterated buffer, the exchange
was terminated with ice-cold quenching buffer composed of D2O and 0.2 mM
DDM (pH 2.5). Ten microliters of pepsin (1.7 mg/ml; Worthington, Lakewood,
NJ, USA) was immediately added to the solution, and the sample was digested
for 10min on ice. Next, the sample (100 ml) was loaded on a Luna 203 2.00mm
C18 column (Phenomenex, Torrance, CA, USA) with a temperature-controlled
Hewlett-Packard autosampler set to 4C. All tubes containing samples (Rho,
Rho*, and Rho*-Gt) then wrapped in aluminum foil, remained unexposed to
ambient light, and the HPLC column was kept submerged in ice during the
experiment. Peptides were eluted with the following gradient sequence:
0–4 min, 98% H2O with 0.1% (v/v) formic acid (A) and 2% acetonitrile with
0.1% (v/v) formic acid (B); 4–12 min, 98% to 2% A. Separation was performed
with an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA,
USA), and the flow rate was 0.2 ml/min. The eluent was injected into a Thermo
Finnigan LXQ (Thermo Scientific, Waltham, MA, USA) MS equipped with an
electrospray ionization source operated in the positive ion mode with other
parameters adjusted as follows. Activation type was set to collision-induced
dissociation, normalized collision energy to 35 kV, capillary temperature to
370C, source voltage to 5 kV, capillary voltage to 43 V, the tube lens to
105 V, and MS spectra were collected over a 200–2,000 mass range. To avoid
sample propagation from one HPLC run to another, each production run was
followed by amock injection of 10 ml of solution A with a resulting HPLC elution
profile identical to the one described previously. This run was followed by
a 20 min equilibration run with 98% A and 2% B for 20 min. Experiments
were performed at least in triplicate for each time point. Experiments for free
Gt were conducted under identical conditions as described previously.
Analysis of Hydrogen-Deuterium Exchange
Peptides resulting from the pepsin digestion were identified by MS/MS em-
ploying the online version of MassMatrix (Xu and Freitas, 2009b). Search
criteria used to identify a peptic digest were as follows. Precursor ion tolerance
was set to 0.8 Da, the maximum number of variable modifications allowed for
each peptide sequence was set to 2, the minimum peptide length was set to 4
amino acids, theminimumpp scorewas set to 5, the pptag score was set to 1.3,
the maximum number of combinations of different modification sites for
a peptide match with modifications was set to 1, and the maximum number
of candidate peptide matches for each spectrum output in the result was set
to 1 (Xu and Freitas, 2007). The product ion tolerance was set to 0.8 Da, and
the mass type was set to average. These search criteria were extended to
include Rho glycosylation sites at N2 and N15, the disulfide bond between
residues C110 and C187, and the palmitoylation sites at C322 and C323
(Table S1, modified residues are shown in bold and underlined). Statistical
significance of the identified peptides was evaluated based on scoring
described elsewhere (Xu et al., 2008). Peptides reproducibly identified are
listed in Table S1; these were used to construct the progress plots. Raw
data in the form of relative signal intensity (%) as a function of m/z were
extracted using XCalibur 2.1.0. Qual Browser was used for a semiautomated
peak detection and deconvolution procedure performed with HDExpress soft-
ware (Weis et al., 2006) just recently described (Orban et al., 2010a). Briefly,
after deuterium uptake was evaluated from the raw data, the value for every
peptide fragment was normalized to 80% of the theoretically maximum
exchangeable sites to account for the 80% deuteration accomplished by the
experimental setup (see Table S1, column 3). For calculations of the maximum
exchangeable sites, only peptide bonds were used to account for the amide
exchange; deuterium exchange from side chains was considered negligible
and was not included. The number of maximum exchangeable sites was
decreased by one for each P residue in a peptide sequence. Hydrogen-deute-
rium exchange was color-coded based on the total percent of the theoretical, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 837
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10%–19%; light blue, 20%–29%; cyan, 30%–39%; green, 40%–49%; yellow,
50%–59%; orange, 60%–69%; red, 70%–79%; pink, 80%–100%. The same
procedure was employed for the free Gt samples as described previously.
Evaluation of Back Exchange
Three synthetic peptides were designed to evaluate the back exchange of
authentic peptide standards. These peptide sequences mimicked fragments
from Rho’s primary C-terminal structure (T336VSKTETSQVAPA), chromophore
binding site (F294AKTSAVYNPVIY), and transmembrane region (M288TIPAF).
Procedures for sample preparation, HPLC elution conditions, MS parameters,
and MS/MS identification of the peptides with MassMatrix (Xu and Freitas,
2009b) were identical to those described under the Experimental Procedures
subsection ‘‘Amide Hydrogen-Deuterium Exchange of Rho.’’
Statistical Analyses
Graphical and statistical analyses were carried out with Origin 8 SR0 software
(version 8.0725, OriginLab Corporation, Northampton, MA, USA). Error bars
represent standard errors of the means (SEM) and statistical significance
was assessed by the Student’s t test. Data represent at least three indepen-
dent experiments. Deuterium uptake is shown as values normalized to the
theoretical maximum of exchangeable sites within each peptide fragment.
The data were fitted to the following equation:
y=D100%  Aek1t;
where k1 represents the rate of uptake and A represents the normalized
deuterium uptake. Dose plots of the fraction unmodified for a modified peptic
fragment as a function of the X-ray exposure time (ms) were fitted to the
following equation:
y= ekt;
where k represents the first-order rate constant and t represents X-ray
exposure time.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two tables, and three figures and can be found with this article online at
doi:10.1016/j.str.2012.03.017.
ACKNOWLEDGMENTS
We would like to thank Susan Farr for ROS and Gt preparation and Dr. Marcin
Golczak for help with the MS. We also thank Dr. Leslie T. Webster, Jr., and
members of the Palczewski laboratory for critical comments on themanuscript
and Rhijuta D’Mello for experimental support at beamline X28C of National
Synchrotron Light Source. This research was supported in part by grantsfrom
the National Institutes of Health (EY008061, GM079191, EB09688,
P30EB09998, and P30EY11373). The National Synchrotron Light Source at
Brookhaven National Laboratory is supported by the Department of Energy
(under contract DE-AC02-98CH10886).
Received: January 14, 2012
Revised: March 5, 2012
Accepted: March 5, 2012
Published: May 8, 2012
REFERENCES
Adare, A., Afanasiev, S., Aidala, C., Ajitanand, N.N., Akiba, Y., Akimoto, R.,
Alexander, J., Al-Ta’ani, H., Andrews, K.R., Angerami, A., et al; PHENIX
Collaboration. (2011). Cross section and parity-violating spin asymmetries of
W± boson production in polarized p + p collisions at sqrt[s] = 500 GeV.
Phys. Rev. Lett. 106, 062001.
Angel, T.E., Chance, M.R., and Palczewski, K. (2009a). Conserved waters
mediate structural and functional activation of family A (rhodopsin-like) G
protein-coupled receptors. Proc. Natl. Acad. Sci. USA 106, 8555–8560.838 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rightsAngel, T.E., Gupta, S., Jastrzebska, B., Palczewski, K., and Chance, M.R.
(2009b). Structural waters define a functional channel mediating activation of
the GPCR, rhodopsin. Proc. Natl. Acad. Sci. USA 106, 14367–14372.
Bayburt, T.H., Leitz, A.J., Xie, G., Oprian, D.D., and Sligar, S.G. (2007).
Transducin activation by nanoscale lipid bilayers containing one and two
rhodopsins. J. Biol. Chem. 282, 14875–14881.
Baylor, D.A., Lamb, T.D., and Yau, K.W. (1979). Responses of retinal rods to
single photons. J. Physiol. 288, 613–634.
Borochov-Neori, H., Fortes, P.A., and Montal, M. (1983). Rhodopsin in recon-
stituted phospholipid vesicles. 2. Rhodopsin-rhodopsin interactions detected
by resonance energy transfer. Biochemistry 22, 206–213.
Busenlehner, L.S., and Armstrong, R.N. (2005). Insights into enzyme structure
and dynamics elucidated by amide H/D exchange mass spectrometry. Arch.
Biochem. Biophys. 433, 34–46.
Cai, K., Langen, R., Hubbell, W.L., and Khorana, H.G. (1997). Structure and
function in rhodopsin: topology of the C-terminal polypeptide chain in relation
to the cytoplasmic loops. Proc. Natl. Acad. Sci. USA 94, 14267–14272.
Choe, H.W., Kim, Y.J., Park, J.H., Morizumi, T., Pai, E.F., Krauss, N., Hofmann,
K.P., Scheerer, P., and Ernst, O.P. (2011). Crystal structure of metarhodopsin
II. Nature 471, 651–655.
Chung, K.Y., Rasmussen, S.G., Liu, T., Li, S., DeVree, B.T., Chae, P.S.,
Calinski, D., Kobilka, B.K., Woods, V.L., Jr., and Sunahara, R.K. (2011).
Conformational changes in the G protein Gs induced by the b2 adrenergic
receptor. Nature 477, 611–615.
Deupi, X., Edwards, P., Singhal, A., Nickle, B., Oprian, D., Schertler, G., and
Standfuss, J. (2012). Stabilized G protein binding site in the structure of consti-
tutively active metarhodopsin-II. Proc. Natl. Acad. Sci. USA 109, 119–124.
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D.A., Engel, A., and Palczewski,
K. (2003). Atomic-force microscopy: Rhodopsin dimers in native disc
membranes. Nature 421, 127–128.
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D.A., Engel, A., and Palczewski,
K. (2004). The G protein-coupled receptor rhodopsin in the native membrane.
FEBS Lett. 564, 281–288.
Goc, A., Angel, T.E., Jastrzebska, B., Wang, B., Wintrode, P.L., and
Palczewski, K. (2008). Different properties of the native and reconstituted
heterotrimeric G protein transducin. Biochemistry 47, 12409–12419.
Grossfield, A., Pitman, M.C., Feller, S.E., Soubias, O., and Gawrisch, K. (2008).
Internal hydration increases during activation of the G-protein-coupled
receptor rhodopsin. J. Mol. Biol. 381, 478–486.
Gupta, S., Sullivan, M., Toomey, J., Kiselar, J., and Chance, M.R. (2007). The
Beamline X28C of the Center for Synchrotron Biosciences: a national resource
for biomolecular structure and dynamics experiments using synchrotron foot-
printing. J. Synchrotron Radiat. 14, 233–243.
Gupta, S., Bavro, V.N., D’Mello, R., Tucker, S.J., Ve´nien-Bryan, C., and
Chance,M.R. (2010). Conformational changes during the gating of a potassium
channel revealed by structural mass spectrometry. Structure 18, 839–846.
Higgins, M.K., Oprian, D.D., and Schertler, G.F. (2006). Recoverin binds
exclusively to an amphipathic peptide at the N terminus of rhodopsin kinase,
inhibiting rhodopsin phosphorylation without affecting catalytic activity of the
kinase. J. Biol. Chem. 281, 19426–19432.
Hurst, D.P., Grossfield, A., Lynch, D.L., Feller, S., Romo, T.D., Gawrisch, K.,
Pitman, M.C., and Reggio, P.H. (2010). A lipid pathway for ligand binding is
necessary for a cannabinoid G protein-coupled receptor. J. Biol. Chem. 285,
17954–17964.
Jastrzebska, B., Fotiadis, D., Jang, G.F., Stenkamp, R.E., Engel, A., and
Palczewski, K. (2006). Functional and structural characterization of rhodopsin
oligomers. J. Biol. Chem. 281, 11917–11922.
Jastrzebska, B., Golczak,M., Fotiadis, D., Engel, A., and Palczewski, K. (2009).
Isolation and functional characterization of a stable complex between photo-
activated rhodopsin and the G protein, transducin. FASEB J. 23, 371–381.
Jastrzebska, B., Tsybovsky, Y., and Palczewski, K. (2010). Complexes
between photoactivated rhodopsin and transducin: progress and questions.
Biochem. J. 428, 1–10.reserved
Structure
Dynamics of Rhodopsin-Transducin ComplexJastrzebska, B., Palczewski, K., and Golczak, M. (2011b). Role of bulk water in
hydrolysis of the rhodopsin chromophore. J. Biol. Chem. 286, 18930–18937.
Jastrzebska, B., Debinski, A., Filipek, S., and Palczewski, K. (2011a). Role of
membrane integrity on G protein-coupled receptors: Rhodopsin stability and
function. Prog. Lipid Res. 50, 267–277.
Jastrzebska, B., Ringler, P., Lodowski, D.T., Moiseenkova-Bell, V., Golczak,
M., Mu¨ller, S.A., Palczewski, K., and Engel, A. (2011c). Rhodopsin-transducin
heteropentamer: three-dimensional structure and biochemical characteriza-
tion. J. Struct. Biol. 176, 387–394.
Kaur, P., Kiselar, J.G., and Chance, M.R. (2009). Integrated algorithms for
high-throughput examination of covalently labeled biomolecules by structural
mass spectrometry. Anal. Chem. 81, 8141–8149.
Konermann, L., Pan, J., and Liu, Y.H. (2011). Hydrogen exchange mass spec-
trometry for studying protein structure and dynamics. Chem. Soc. Rev. 40,
1224–1234.
Langen, R., Cai, K., Altenbach, C., Khorana, H.G., and Hubbell, W.L. (1999).
Structural features of the C-terminal domain of bovine rhodopsin: a site-
directed spin-labeling study. Biochemistry 38, 7918–7924.
Li, J., Edwards, P.C., Burghammer, M., Villa, C., and Schertler, G.F. (2004).
Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343,
1409–1438.
Lodowski, D.T., Salom, D., Le Trong, I., Teller, D.C., Ballesteros, J.A.,
Palczewski, K., and Stenkamp, R.E. (2007). Crystal packing analysis of
Rhodopsin crystals. J. Struct. Biol. 158, 455–462.
Majumdar, S., Ramachandran, S., and Cerione, R.A. (2004). Perturbing the
linker regions of the alpha-subunit of transducin: a new class of constitutively
active GTP-binding proteins. J. Biol. Chem. 279, 40137–40145.
Mansoor, S.E., Palczewski, K., and Farrens, D.L. (2006). Rhodopsin self-asso-
ciates in asolectin liposomes. Proc. Natl. Acad. Sci. USA 103, 3060–3065.
Meyer, E. (1992). Internal water molecules and H-bonding in biological macro-
molecules: a review of structural features with functional implications. Protein
Sci. 1, 1543–1562.
Nakamichi, H., and Okada, T. (2006a). Crystallographic analysis of primary
visual photochemistry. Angew. Chem. Int. Ed. Engl. 45, 4270–4273.
Nakamichi, H., and Okada, T. (2006b). Local peptide movement in the photo-
reaction intermediate of rhodopsin. Proc. Natl. Acad. Sci. USA 103, 12729–
12734.
Nakamichi, H., and Okada, T. (2007). X-ray crystallographic analysis of 9-cis-
rhodopsin, a model analogue visual pigment. Photochem. Photobiol. 83,
232–235.
Nickell, S., Park, P.S., Baumeister, W., and Palczewski, K. (2007). Three-
dimensional architecture of murine rod outer segments determined by cryoe-
lectron tomography. J. Cell Biol. 177, 917–925.
Okada, T. (2004). X-ray crystallographic studies for ligand-protein interaction
changes in rhodopsin. Biochem. Soc. Trans. 32, 738–741.
Okada, T., Le Trong, I., Fox, B.A., Behnke, C.A., Stenkamp, R.E., and
Palczewski, K. (2000). X-Ray diffraction analysis of three-dimensional crystals
of bovine rhodopsin obtained from mixed micelles. J. Struct. Biol. 130, 73–80.
Okada, T., Sugihara, M., Bondar, A.N., Elstner, M., Entel, P., and Buss, V.
(2004). The retinal conformation and its environment in rhodopsin in light of
a new 2.2 A crystal structure. J. Mol. Biol. 342, 571–583.
Orban, T., Bereta, G., Miyagi, M., Wang, B., Chance, M.R., Sousa, M.C., and
Palczewski, K. (2010a). Conformational changes in guanylate cyclase-acti-
vating protein 1 induced by Ca2+ and N-terminal fatty acid acylation.
Structure 18, 116–126.
Orban, T., Gupta, S., Palczewski, K., and Chance, M.R. (2010b). Visualizing
water molecules in transmembrane proteins using radiolytic labeling methods.
Biochemistry 49, 827–834.
Palczewski, K. (2006). G protein-coupled receptor rhodopsin. Annu. Rev.
Biochem. 75, 743–767.
Palczewski, K. (2010). Oligomeric forms of G protein-coupled receptors
(GPCRs). Trends Biochem. Sci. 35, 595–600.Structure 20Palczewski,K.,Buczy1ko,J.,Kaplan,M.W.,Polans,A.S., andCrabb,J.W. (1991).
Mechanism of rhodopsin kinase activation. J. Biol. Chem. 266, 12949–12955.
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A.,Motoshima, H., Fox,B.A.,
Le Trong, I., Teller, D.C., Okada, T., Stenkamp, R.E., et al. (2000). Crystal
structure of rhodopsin: A G protein-coupled receptor. Science 289, 739–745.
Papermaster, D.S. (1982). Preparation of retinal rod outer segments. Methods
Enzymol. 81, 48–52.
Park, P.S., and Palczewski, K. (2005). Diversifying the repertoire of G protein-
coupled receptors through oligomerization. Proc. Natl. Acad. Sci. USA 102,
8793–8794.
Park, P.S., Lodowski, D.T., and Palczewski, K. (2008). Activation of G protein-
coupled receptors: beyond two-state models and tertiary conformational
changes. Annu. Rev. Pharmacol. Toxicol. 48, 107–141.
Phillips, W.J., and Cerione, R.A. (1994). A C-terminal peptide of bovine
rhodopsin binds to the transducin alpha-subunit and facilitates its activation.
Biochem. J. 299, 351–357.
Rasmussen, S.G., Choi, H.J., Fung, J.J., Pardon, E., Casarosa, P., Chae, P.S.,
Devree, B.T., Rosenbaum, D.M., Thian, F.S., Kobilka, T.S., et al. (2011).
Structure of a nanobody-stabilized active state of the b(2) adrenoceptor.
Nature 469, 175–180.
Rivero-Mu¨ller, A., Chou, Y.Y., Ji, I., Lajic, S., Hanyaloglu, A.C., Jonas, K.,
Rahman, N., Ji, T.H., and Huhtaniemi, I. (2010). Rescue of defective G
protein-coupled receptor function in vivo by intermolecular cooperation.
Proc. Natl. Acad. Sci. USA 107, 2319–2324.
Salom, D., Le Trong, I., Pohl, E., Ballesteros, J.A., Stenkamp, R.E., Palczewski,
K., and Lodowski, D.T. (2006a). Improvements in G protein-coupled receptor
purification yield light stable rhodopsin crystals. J. Struct. Biol. 156, 497–504.
Salom, D., Lodowski, D.T., Stenkamp, R.E., Le Trong, I., Golczak, M.,
Jastrzebska, B., Harris, T., Ballesteros, J.A., and Palczewski, K. (2006b).
Crystal structure of a photoactivated deprotonated intermediate of rhodopsin.
Proc. Natl. Acad. Sci. USA 103, 16123–16128.
Scheerer, P., Park, J.H., Hildebrand, P.W., Kim, Y.J., Krauss, N., Choe, H.W.,
Hofmann, K.P., and Ernst, O.P. (2008). Crystal structure of opsin in its
G-protein-interacting conformation. Nature 455, 497–502.
Standfuss, J., Xie, G., Edwards, P.C., Burghammer, M., Oprian, D.D., and
Schertler, G.F. (2007). Crystal structure of a thermally stable rhodopsinmutant.
J. Mol. Biol. 372, 1179–1188.
Standfuss, J., Edwards, P.C., D’Antona, A., Fransen, M., Xie, G., Oprian, D.D.,
and Schertler, G.F. (2011). The structural basis of agonist-induced activation in
constitutively active rhodopsin. Nature 471, 656–660.
Stenkamp, R.E. (2008). Alternative models for two crystal structures of bovine
rhodopsin. Acta Crystallogr. D Biol. Crystallogr. D64, 902–904.
Struts, A.V., Salgado, G.F., and Brown, M.F. (2011a). Solid-state 2H NMR
relaxation illuminates functional dynamics of retinal cofactor in membrane
activation of rhodopsin. Proc. Natl. Acad. Sci. USA 108, 8263–8268.
Struts, A.V., Salgado, G.F., Martı´nez-Mayorga, K., and Brown, M.F. (2011b).
Retinal dynamics underlie its switch from inverse agonist to agonist during
rhodopsin activation. Nat. Struct. Mol. Biol. 18, 392–394.
Teller, D.C., Okada, T., Behnke, C.A., Palczewski, K., and Stenkamp, R.E.
(2001). Advances in determination of a high-resolution three-dimensional
structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs).
Biochemistry 40, 7761–7772.
Vogel, R., Martell, S., Mahalingam, M., Engelhard, M., and Siebert, F. (2007).
Interaction of a G protein-coupled receptor with a G protein-derived peptide
induces structural changes in both peptide and receptor: a Fourier-transform
infrared study using isotopically labeled peptides. J. Mol. Biol. 366, 1580–
1588.
Weis, D.D., Engen, J.R., and Kass, I.J. (2006). Semi-automated data process-
ing of hydrogen exchange mass spectra using HX-Express. J. Am. Soc. Mass
Spectrom. 17, 1700–1703.
West, G.M., Chien, E.Y., Katritch, V., Gatchalian, J., Chalmers, M.J., Stevens,
R.C., and Griffin, P.R. (2011). Ligand-dependent perturbation of the conforma-
tional ensemble for the GPCR b2 adrenergic receptor revealed by HDX.
Structure 19, 1424–1432., 826–840, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 839
Structure
Dynamics of Rhodopsin-Transducin ComplexWhorton, M.R., Bokoch, M.P., Rasmussen, S.G., Huang, B., Zare, R.N.,
Kobilka, B., and Sunahara, R.K. (2007). A monomeric G protein-coupled
receptor isolated in a high-density lipoprotein particle efficiently activates its
G protein. Proc. Natl. Acad. Sci. USA 104, 7682–7687.
Xu, G., and Chance, M.R. (2004). Radiolytic modification of acidic amino acid
residues in peptides: probes for examining protein-protein interactions. Anal.
Chem. 76, 1213–1221.
Xu, G., and Chance, M.R. (2005). Radiolytic modification of sulfur-containing
amino acid residues in model peptides: fundamental studies for protein foot-
printing. Anal. Chem. 77, 2437–2449.
Xu, G., and Chance, M.R. (2007). Hydroxyl radical-mediated modification of
proteins as probes for structural proteomics. Chem. Rev. 107, 3514–3543.
Xu, G., Takamoto, K., and Chance, M.R. (2003). Radiolytic modification of
basic amino acid residues in peptides: probes for examining protein-protein
interactions. Anal. Chem. 75, 6995–7007.840 Structure 20, 826–840, May 9, 2012 ª2012 Elsevier Ltd All rightsXu, H., and Freitas, M.A. (2007). A mass accuracy sensitive probability based
scoring algorithm for database searching of tandem mass spectrometry data.
BMC Bioinformatics.
Xu, H., and Freitas, M.A. (2009a). Automated diagnosis of LC-MS/MS perfor-
mance. Bioinformatics 25, 1341–1343.
Xu, H., and Freitas, M.A. (2009b). MassMatrix: a database search program for
rapid characterization of proteins and peptides from tandem mass spectrom-
etry data. Proteomics 9, 1548–1555.
Xu, H., Zhang, L., and Freitas, M.A. (2008). Identification and characterization
of disulfide bonds in proteins and peptides from tandemMS data by use of the
MassMatrix MS/MS search engine. J. Proteome Res. 7, 138–144.
Zhang, X., Chien, E.Y., Chalmers, M.J., Pascal, B.D., Gatchalian, J., Stevens,
R.C., and Griffin, P.R. (2010). Dynamics of the beta2-adrenergic G-protein
coupled receptor revealed by hydrogen-deuterium exchange. Anal. Chem.
82, 1100–1108.reserved
